Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Rimbert, Marie ^a,b,c,d   Hamidou, Mohamed ^a,d   Braudeau, Cécile ^a,b   Puéchal, Xavier ^e   Teixeira, Luis ^f,g   Caillon, Hélène ^a   Néel, Antoine ^a,d   Audrain, Marie ^a   Guillevin, Loic ^f,g   Josien, Régis ^a,b,c,d  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Institut de Recherche en Transplantation   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE NANTES   (France)

^e CENTRE HOSPITALIER DU MANS   (France)

^f CH Le Mans Service de Rhumatologie ^*  (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD39 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; L SELECTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ANCA ASSOCIATED VASCULITIS; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CD4+ CD25+ T LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE EXACERBATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; PATHOGENESIS; PHENOTYPE; REGULATORY T LYMPHOCYTE; REMISSION; TH17 CELL; ACUTE DISEASE; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ACUTE DISEASE; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CASE-CONTROL STUDIES; CELL COUNT; COCULTURE TECHNIQUES; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-17; L-SELECTIN; MIDDLE AGED; REMISSION INDUCTION; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 79954468454     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018734     Document Type: Article

References (63)

1. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, et al. (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1: 425-429.
2. Falk RJ, Jennette JC, (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318: 1651-1657.
3. Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, et al. (2000) Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 43: 2025-2033.
4. Gomez-Puerta JA, Bosch X, (2009) Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update. Am J Pathol 175: 1790-1798.
5. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, et al. (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110: 955-963.
6. Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, et al. (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 14: 1088-1096.
7. Clayton AR, Savage CO, (2000) What you should know about PR3-ANCA. Evidence for the role of T cells in the pathogenesis of systemic vasculitis. Arthritis Res 2: 260-262.
8. Lamprecht P, (2005) Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 141: 201-210.
9. Abdulahad WH, Stegeman CA, Kallenberg CG, (2009) Review article: The role of CD4(+) T cells in ANCA-associated systemic vasculitis. Nephrology (Carlton) 14: 26-32.
10. Brouwer E, Tervaert JW, Horst G, Huitema MG, van der Giessen M, et al. (1991) Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 83: 379-386.
11. Abdulahad WH, van der Geld YM, Stegeman CA, Kallenberg CG, (2006) Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney Int 70: 938-947.
12. Marinaki S, Neumann I, Kalsch AI, Grimminger P, Breedijk A, et al. (2005) Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis. Clin Exp Immunol 140: 181-191.
13. Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, et al. (2007) Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 56: 2080-2091.
14. Sakaguchi S, (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
15. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, et al. (2005) Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54: 92-99.
16. Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR, et al. (2004) Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199: 1285-1291.
17. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, et al. (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200: 277-285.
18. Mottonen M, Heikkinen J, Mustonen L, Isomaki P, Luukkainen R, et al. (2005) CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 140: 360-367.
19. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265.
20. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, et al. (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232.
21. Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, et al. (2009) CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 183: 7602-7610.
22. Banchereau J, Steinman RM, (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
23. Steinman RM, Nussenzweig MC, (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 99: 351-358.
24. Shortman K, Liu YJ, (2002) Mouse and human dendritic cell subtypes. Nat Rev Immunol 2: 151-161.
25. Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, et al. (2007) Dendritic cell subsets in health and disease. Immunol Rev 219: 118-142.
26. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, et al. (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837.
27. Csernok E, Ai M, Gross WL, Wicklein D, Petersen A, et al. (2006) Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood 107: 4440-4448.
28. Diacovo TG, Blasius AL, Mak TW, Cella M, Colonna M, (2005) Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes. J Exp Med 202: 687-696.
29. Cheong C, Matos I, Choi JH, Dandamudi DB, Shrestha E, et al. (2010) Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 143: 416-429.
30. Popa ER, Stegeman CA, Bos NA, Kallenberg CG, Tervaert JW, (1999) Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol 103: 885-894.
31. Blomberg S, Eloranta ML, Magnusson M, Alm GV, Ronnblom L, (2003) Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 48: 2524-2532.
32. Migita K, Miyashita T, Maeda Y, Kimura H, Nakamura M, et al. (2005) Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus. Clin Exp Immunol 142: 84-91.
33. Ciccocioppo R, Ricci G, Rovati B, Pesce I, Mazzocchi S, et al. (2007) Reduced number and function of peripheral dendritic cells in coeliac disease. Clin Exp Immunol 149: 487-496.
34. Jongbloed SL, Lebre MC, Fraser AR, Gracie JA, Sturrock RD, et al. (2006) Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res Ther 8: R15.
35. Huang ZX, Zheng BR, Li TW, Lu YM, Gu JR, et al. (2009) [Study on expressions of CD25 and CD127 in CD4+ peripheral T lymphocytes of patients with rheumatoid arthritis]. Zhonghua Yi Xue Za Zhi 89: 2476-2480.
36. Wilde B, van Paassen P, Damoiseaux J, Heerings-Rewinkel P, van Rie H, et al. (2009) Dendritic cells in renal biopsies of patients with ANCA-associated vasculitis. Nephrol Dial Transplant 24: 2151-2156.
37. Morgan MD, Day CJ, Piper KP, Khan N, Harper L, et al. (2010) Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells. Immunology.
38. Klapa S, Mueller A, Csernok E, Fagin U, Klenerman P, et al. (2005) Lower numbers of FoxP3 and CCR4 co-expressing cells in an elevated subpopulation of CD4+CD25high regulatory T cells from Wegener's granulomatosis. Clin Exp Rheumatol 28: 72-80.
39. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA, (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199: 971-979.
40. Michel L, Berthelot L, Pettre S, Wiertlewski S, Lefrere F, et al. (2008) Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis. J Clin Invest 118: 3411-3419.
41. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500.
42. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, et al. (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19: 345-354.
43. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701-1711.
44. Mahnke K, Qian Y, Knop J, Enk AH, (2003) Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101: 4862-4869.
45. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, et al. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6: 1219-1227.
46. Yamazaki S, Iyoda T, Tarbell K, Olson K, Velinzon K, et al. (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198: 235-247.
47. Yamazaki S, Bonito AJ, Spisek R, Dhodapkar M, Inaba K, et al. (2007) Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors. Blood 110: 4293-4302.
48. Pasare C, Medzhitov R, (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
49. Banerjee DK, Dhodapkar MV, Matayeva E, Steinman RM, Dhodapkar KM, (2006) Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108: 2655-2661.
50. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, et al. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
51. Darrasse-Jeze G, Deroubaix S, Mouquet H, Victora GD, Eisenreich T, et al. (2009) Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 206: 1853-1862.
52. Bigley V, Haniffa M, Doulatov S, Wang XN, Dickinson R, et al. (2011) The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 208: 227-234.
53. Ouabed A, Hubert FX, Chabannes D, Gautreau L, Heslan M, et al. (2008) Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells. J Immunol 180: 5862-5870.
54. Lehmann J, Huehn J, de la Rosa M, Maszyna F, Kretschmer U, et al. (2002) Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc Natl Acad Sci U S A 99: 13031-13036.
55. Mandapathil M, Lang S, Gorelik E, Whiteside TL, (2009) Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods 346: 55-63.
56. Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, et al. (2008) Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28: 870-880.
57. Emamaullee JA, Davis J, Merani S, Toso C, Elliott JF, et al. (2009) Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 58: 1302-1311.
58. Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG, (2008) Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 58: 2196-2205.
59. Nogueira E, Hamour S, Sawant D, Henderson S, Mansfield N, et al. (2010) Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant.
60. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
61. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM, (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
62. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, et al. (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231-234.
63. Yang J, Chu Y, Yang X, Gao D, Zhu L, et al. (2009) Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 60: 1472-1483.